logo

Enter Symbol

AKORN INC(NSDQ:AKRX)
Akorn, Inc. manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others. They also market ophthalmic surgical instruments and related products. Customers include physicians, optometrists, wholesalers, group purchasing organizations and otherpharmaceutical companies. They also provide contract manufacturingservices.
# Employees: 13
Address: 2500 Millbrook Drive,Buffalo Grove,IL,USA
Phone: 847 279-6100
Fax: 847 279-6123
Website: www.akorn.com
Email: investor.relations@akorn.com
Sector: Medical
Industry: MED-GENERIC DRG
Executive Officers
John Kapoor Dr. (Chmn.; Dir.)
Arthur S. Przybyl (C.E.O.)
Jeffrey A. Whitnell (C.F.O.; Princ. Acctg. Off.)
Jerry N. Ellis (Dir.)
Jerry Treppel (Dir.,)
Dividend
Ex-Dividend Date: N/A
Annual Dividend: N/A
Current Dividend Yield: N/A
Dividend Paid (3 months): N/A
Indicated Dividend: N/A
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/10/2010
Mean EPS (Next Qtr): ($0.02)
Mean EPS (Year): ($0.17)
Mean Estimate(Long Term): ($0.01)
P/E Ratio(Based on EPS estimate): -0.010
Number of Estimates: 1
Shares Performance
Period AKRX Compare to S&P
YTD -30.00 % -42.07 %
4 Weeks 6.62 % 5.47 %
12 Weeks 24.81 % 17.67 %
Shares Information
Analyst Coverage: Y
Avg Volume: 406548
Shares Outstanding: 90M
Market Cap: $0.15B
52 Week High: $2.69
52 Week Low: $0.75
P/E Ratio: -0.010
PEG Ratio: -0.010
Split: On 1/1/1990 AKRX split by factor of 1.500
Earnings Performance
EPS Growth in Last Quarter: 42.86 %
EPS Growth in Last Year: -233.33 %
Sales Growth in Last Quarter: 18.84 %
Sales Growth in Last Quarter: -39.23 %
Financials
Qtr Book Value: $3.22
Cash Flow/Share: ($0.01)
Change in Payout Ratio: -0.010
Price/Sales: 1.740
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia